lobbying_filings_raw: 60f6fe9d-e22e-4872-875f-cf7d0fd3ad2f
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60f6fe9d-e22e-4872-875f-cf7d0fd3ad2f | Q4 | 322897 | NAHIGIAN STRATEGIES, LLC | 187028 | TEVA PHARMACEUTICALS USA INC | 2014 | fourth_quarter | 2015-01-14T10:29:03.693000-05:00 | 45000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/60f6fe9d-e22e-4872-875f-cf7d0fd3ad2f/", "filing_uuid": "60f6fe9d-e22e-4872-875f-cf7d0fd3ad2f", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2014, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/60f6fe9d-e22e-4872-875f-cf7d0fd3ad2f/print/", "filing_document_content_type": "text/html", "income": "45000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "KENNETH NAHIGIAN", "dt_posted": "2015-01-14T10:29:03.693000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1001 19th Street, Suite 1200", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Arlington", "registrant_state": "VA", "registrant_zip": "22209", "registrant": {"id": 322897, "url": "https://lda.senate.gov/api/v1/registrants/322897/", "house_registrant_id": null, "name": "NAHIGIAN STRATEGIES, LLC", "description": "Coalition of mothers advocating for access to therapies for epilepsy", "address_1": "1001 19th Street, Suite 1200", "address_2": null, "address_3": null, "address_4": null, "city": "Arlington", "state": "VA", "state_display": "Virginia", "zip": "22209", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KENNETH NAHIGIAN", "contact_telephone": "+1 703-567-6996", "dt_updated": "2022-04-06T16:08:31.636334-04:00"}, "client": {"id": 187028, "url": "https://lda.senate.gov/api/v1/clients/187028/", "client_id": 24, "name": "TEVA PHARMACEUTICALS USA INC", "general_description": "Pharmaceutical Manufacturer", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "PA", "ppb_state_display": "Pennsylvania", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2009-06-15"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Issues related to generic drug exclusivity.", "foreign_entity_issues": "Teva Pharmaceuticals is an Israeli-based company.", "lobbyists": [{"lobbyist": {"id": 49676, "prefix": "mr", "prefix_display": "MR.", "first_name": "KENNETH", "nickname": null, "middle_name": "ROBERT", "last_name": "NAHIGIAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |